Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Total 13F shares
-
101,329,623
-
Share change
-
+19,853,237
-
Total reported value
-
$1,984,124,290
-
Put/Call ratio
-
73%
-
Price per share
-
$19.53
-
Number of holders
-
234
-
Value change
-
+$387,248,263
-
Number of buys
-
136
-
Number of sells
-
77
Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q1 2025
As of 31 Mar 2025 Beam Therapeutics Inc. - COMMON STOCK (BEAM) had 234 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 101,329,623 shares of stock of the company.
Largest 10 holders included FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ARK Investment Management LLC, BlackRock, Inc., FMR LLC, ARCH Venture Management, LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 234 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.